INCR1 and glioblastoma: We also showed that IL12 treatment of patient-derived GBM cells co-cultured with PBMCs stimulated INCR1 expression and the upregulation of PD-L1 and several other immunosuppressive molecules, including immune checkpoints, immunosuppressive enzymes, and immunosuppressive cytokines.